Letters to the Editor

Amphiregulin as a biomarker for monitoring lifethreatening acute graft-versus-host disease: secondary analysis of two prospective clinical trials

University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN; Fred Hutchinson Cancer Center
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
Incyte Corporation, Wilmington, DE
University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
Incyte Corporation, Wilmington, DE
Vol. 109 No. 5 (2024): May, 2024 https://doi.org/10.3324/haematol.2023.283215